180 Wealth Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

180 Wealth Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,383	Closed	-$253K	–	266
2019 Q1	$253K	Sell	1,383 -47	-3%	-$6.99K	0.11%	215
2018 Q4	$247K	Hold	1,430	–	–	0.12%	210
2018 Q3	$247K	Sell	1,430 -486	-25%	-$70.1K	0.11%	210
2018 Q2	$267K	Buy	+1,916	New	+$272K	0.13%	192
2018 Q1	–	Sell	-1,622	Closed	-$214K	–	256
2017 Q4	$214K	Buy	+1,622	New	+$191K	0.11%	219

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

180 Wealth Advisors's GWPH Position: Q2 2019 in Review

180 Wealth Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2019, closing a stake of 1,383 shares — an estimated $253K sold.

180 Wealth Advisors first reported a position in GWPH in Q4 2017 and held it in 5 quarters. The position peaked at $267K in Q2 2018. 318 funds tracked by Wall St. Rank hold GWPH as of Q2 2019.

180 Wealth Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
180 Wealth Advisors sold 1,383 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2019, an estimated $253K.
180 Wealth Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2017 and held it in 5 quarters.
180 Wealth Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $267K in Q2 2018.
318 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2019.

Based on 180 Wealth Advisors's 13F filing for Q2 2019, filed 5 Aug 2019.